Shares of Colgate-Palmolive Company (NYSE:CL – Get Free Report) have earned a consensus recommendation of “Hold” from the twenty brokerages that are covering the company, Marketbeat reports. One analyst has rated the stock with a sell rating, nine have given a hold rating and ten have given a buy rating to the company. The average twelve-month target price among brokers that have covered the stock in the last year is $102.12.
Several equities analysts have recently issued reports on the stock. Citigroup lifted their price objective on shares of Colgate-Palmolive from $103.00 to $108.00 and gave the stock a “buy” rating in a research note on Monday, April 28th. Wall Street Zen downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Wednesday, May 7th. UBS Group raised their price objective on Colgate-Palmolive from $105.00 to $109.00 and gave the stock a “buy” rating in a research note on Thursday, April 17th. Wells Fargo & Company upped their target price on Colgate-Palmolive from $83.00 to $88.00 and gave the company an “underweight” rating in a report on Wednesday, April 2nd. Finally, JPMorgan Chase & Co. increased their price target on Colgate-Palmolive from $95.00 to $103.00 and gave the company an “overweight” rating in a research report on Monday, April 28th.
Read Our Latest Research Report on Colgate-Palmolive
Hedge Funds Weigh In On Colgate-Palmolive
Colgate-Palmolive Trading Down 1.6%
Shares of NYSE CL opened at $88.66 on Wednesday. The stock’s 50 day moving average price is $91.75 and its two-hundred day moving average price is $90.93. Colgate-Palmolive has a 52-week low of $85.32 and a 52-week high of $109.30. The stock has a market capitalization of $71.85 billion, a P/E ratio of 25.04, a PEG ratio of 4.79 and a beta of 0.38. The company has a quick ratio of 0.54, a current ratio of 0.85 and a debt-to-equity ratio of 8.96.
Colgate-Palmolive (NYSE:CL – Get Free Report) last announced its quarterly earnings results on Friday, April 25th. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.86 by $0.05. Colgate-Palmolive had a net margin of 14.52% and a return on equity of 461.04%. The company had revenue of $4.91 billion during the quarter, compared to the consensus estimate of $4.92 billion. During the same quarter in the previous year, the company posted $0.86 earnings per share. The company’s revenue for the quarter was down 3.0% compared to the same quarter last year. On average, analysts anticipate that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.
Colgate-Palmolive Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, August 15th. Investors of record on Friday, July 18th will be given a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a yield of 2.35%. The ex-dividend date of this dividend is Friday, July 18th. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 58.76%.
Colgate-Palmolive declared that its board has initiated a stock repurchase program on Thursday, March 20th that authorizes the company to buyback $5.00 billion in outstanding shares. This buyback authorization authorizes the company to reacquire up to 6.8% of its stock through open market purchases. Stock buyback programs are often an indication that the company’s board believes its stock is undervalued.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Articles
- Five stocks we like better than Colgate-Palmolive
- Investing In Preferred Stock vs. Common Stock
- Analyst Downgrades Joby, But Overlooks Major Regulatory Wins
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- U.S. Steel Stock Burns the Bears With Surprise Upside Move
- Short Selling – The Pros and Cons
- Lululemon, UNH, Enphase: Bad News, Good Opportunity?
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.